Resolute Integrity drug eluting stent safety and efficacy for the treatment of coronary artery disease

olute Integrity drug eluting stent safety and efficacy for the treatment of coronary artery disease Review (423) Total Article Views Authors: Burgos JD, Farrag S, Mukherjee D Video abstract presented by Debabrata Mukherjee Views: 69 Published Date February 2013 Volume 2013:4 Pages 23 - 37 DOI: http://dx.doi.org/10.2147/RRCC.S31012 Received: 05 December 2012 Accepted: 04 January 2013 Published: 22 February 2013 Jose D Burgos, Safa Farrag, Debabrata Mukherjee Department of Internal Medicine, Paul L Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA Abstract: The need to develop a local antirestenotic mechanism to prevent in-stent thrombosis has driven the development of new generation stents. The Resolute Integrity stent is a zotarolimus-eluting system with a new BioLinx polymer that allows a slower drug elution. Recently available data has shown the clinical efficacy and safety of this stent in randomized and observational studies. The Resolute Integrity stent system has demonstrated noninferiority when compared with other stents and holds the promise to treat more complex coronary lesions.